Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction

Multiple sclerosis (MS) is a chronic progressive disease of the central nervous system common among young people. Neurogenic bladder often is a common symptom of the disease. Young people with MS often have to make treatment and family planning decisions at the same time. The possibility of realizin...

Full description

Saved in:
Bibliographic Details
Main Authors: E. I. Luzanova, M. I. Karpova, O. S. Abramovskikh, E. A. Chetvernina, S. V. Kupriyanov
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2024-07-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/5671
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241385964666880
author E. I. Luzanova
M. I. Karpova
O. S. Abramovskikh
E. A. Chetvernina
S. V. Kupriyanov
author_facet E. I. Luzanova
M. I. Karpova
O. S. Abramovskikh
E. A. Chetvernina
S. V. Kupriyanov
author_sort E. I. Luzanova
collection DOAJ
description Multiple sclerosis (MS) is a chronic progressive disease of the central nervous system common among young people. Neurogenic bladder often is a common symptom of the disease. Young people with MS often have to make treatment and family planning decisions at the same time. The possibility of realizing reproductive plans is closely related to urological complications of the disease, high risk of urinary tract infections, and sexual dysfunction. In addition, disease modifying therapies for MS play a significant role in increasing the likelihood of infectious complications. Therefore, the issue of infection prevention in MS is critical. Effective personalized prevention of urogenital infections is possible with a clear understanding of the microbiota composition. DNA sequencing methods have changed the conventional idea that normal urine is sterile and gave rise to the concepts of asymptomatic bacteriuria in healthy people. Moreover, data on the genitourobiome of patients with neurological diseases have recently emerged. Extended knowledge about the microbiology in the genitourinary system of neurological patients is necessary to unleash the capacity of health-preserving technologies. The aim of the review was to integrate currently available data concerning the microbiocenosis of the lower urinary tract and vagina with underlying neurogenic pelvic dysfunction, including MS, as well as to present data on the association between closely located biotopes and the effect of MS therapy on the risks of developing genitourinary infections.
format Article
id doaj-art-20ce1ac2fc23484bb8467284351e24c4
institution Kabale University
issn 1682-0363
1819-3684
language English
publishDate 2024-07-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj-art-20ce1ac2fc23484bb8467284351e24c42025-08-20T04:00:12ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842024-07-0123213314110.20538/1682-0363-2024-2-133-1413080Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunctionE. I. Luzanova0M. I. Karpova1O. S. Abramovskikh2E. A. Chetvernina3S. V. Kupriyanov4South Ural State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical University; National Research Tomsk State UniversityMultiple sclerosis (MS) is a chronic progressive disease of the central nervous system common among young people. Neurogenic bladder often is a common symptom of the disease. Young people with MS often have to make treatment and family planning decisions at the same time. The possibility of realizing reproductive plans is closely related to urological complications of the disease, high risk of urinary tract infections, and sexual dysfunction. In addition, disease modifying therapies for MS play a significant role in increasing the likelihood of infectious complications. Therefore, the issue of infection prevention in MS is critical. Effective personalized prevention of urogenital infections is possible with a clear understanding of the microbiota composition. DNA sequencing methods have changed the conventional idea that normal urine is sterile and gave rise to the concepts of asymptomatic bacteriuria in healthy people. Moreover, data on the genitourobiome of patients with neurological diseases have recently emerged. Extended knowledge about the microbiology in the genitourinary system of neurological patients is necessary to unleash the capacity of health-preserving technologies. The aim of the review was to integrate currently available data concerning the microbiocenosis of the lower urinary tract and vagina with underlying neurogenic pelvic dysfunction, including MS, as well as to present data on the association between closely located biotopes and the effect of MS therapy on the risks of developing genitourinary infections.https://bulletin.ssmu.ru/jour/article/view/5671multiple sclerosisneurogenic bladdervaginosismicrobiota
spellingShingle E. I. Luzanova
M. I. Karpova
O. S. Abramovskikh
E. A. Chetvernina
S. V. Kupriyanov
Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction
Бюллетень сибирской медицины
multiple sclerosis
neurogenic bladder
vaginosis
microbiota
title Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction
title_full Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction
title_fullStr Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction
title_full_unstemmed Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction
title_short Urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction
title_sort urinary tract microbiota in patients with multiple sclerosis and neurogenic pelvic dysfunction
topic multiple sclerosis
neurogenic bladder
vaginosis
microbiota
url https://bulletin.ssmu.ru/jour/article/view/5671
work_keys_str_mv AT eiluzanova urinarytractmicrobiotainpatientswithmultiplesclerosisandneurogenicpelvicdysfunction
AT mikarpova urinarytractmicrobiotainpatientswithmultiplesclerosisandneurogenicpelvicdysfunction
AT osabramovskikh urinarytractmicrobiotainpatientswithmultiplesclerosisandneurogenicpelvicdysfunction
AT eachetvernina urinarytractmicrobiotainpatientswithmultiplesclerosisandneurogenicpelvicdysfunction
AT svkupriyanov urinarytractmicrobiotainpatientswithmultiplesclerosisandneurogenicpelvicdysfunction